Atlas Trials

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Clinical trial NCT00122265 · TERMINATED

Trial details

NCT number
NCT00122265
Sponsor
AHS Cancer Control Alberta
Status
TERMINATED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2003-04-01
Primary completion
2012-01-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.